Viewing StudyNCT00024661



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00024661
Status: COMPLETED
Last Update Posted: 2011-04-13
First Post: 2001-09-24

Brief Title: Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
Sponsor: INSYS Therapeutics Inc
Organization: INSYS Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Keywords:
Name View
recurrent solid tumors View
liposomes containing AON to c-raf protein LErafAON View